Tag:

colon cancer

Health

Mailed DNA-based test for colorectal cancer screening

by Chief Editor
written by Chief Editor

The Evolution of Colorectal Cancer Screening: Moving Beyond the Clinic

For years, the biggest hurdle in colorectal cancer (CRC) prevention hasn’t always been the technology available, but rather the logistics of getting patients to use it. In underserved community health centers, where patients face significant social and economic barriers, the traditional “come into the office” model is often where screening efforts fail.

Recent data published in JAMA Internal Medicine suggests a pivotal shift in how we approach this challenge. By moving the screening process from the clinic to the patient’s mailbox, healthcare providers are seeing a measurable increase in participation, particularly when using advanced DNA-based testing.

Did you know? Colorectal cancer is currently the second most common cause of cancer-related deaths in the United States. Because timely screening can reduce both incidence and mortality, closing the “screening gap” is a public health priority.

FIT vs. FIT-DNA: Which Mailed Approach Wins?

When comparing the standard fecal immunochemical test (FIT) with the newer FIT-DNA test, the results are clear: a more comprehensive test combined with better support leads to higher uptake. A large-scale study involving 5,127 individuals across community health centers in Greater Boston and Los Angeles highlighted several key advantages of the FIT-DNA approach.

Higher Participation Rates

The study found that participants randomized to the FIT-DNA group showed significantly higher screening participation at both the 90-day and 180-day marks compared to those using standard FIT. Not only were more people completing the tests, but they were doing so faster.

Higher Participation Rates
Screening Manufacturer Sensitivity and Frequency

The Power of Manufacturer Support

One of the most interesting trends is the role of the manufacturer. While FIT kits often rely on automated text reminders from clinic staff, FIT-DNA is frequently paired with a structured outreach and support program provided by the manufacturer. This reduced burden on community health center staff while providing patients with a higher level of guidance.

Sensitivity and Frequency

FIT-DNA offers higher sensitivity than the standard FIT. Because This proves typically performed every three years rather than annually, patients may be more motivated to complete the process knowing the interval between tests is longer.

From Instagram — related to Sensitivity and Frequency, Pro Tip for Providers

Addressing Regional and Demographic Disparities

Screening is not one-size-fits-all. The data reveals that regional characteristics heavily influence how patients respond to outreach. For instance, while overall participation was higher in Boston, the relative advantage of FIT-DNA over FIT was more pronounced in Los Angeles.

In the Los Angeles cohort, participants were largely Hispanic, Spanish-speaking, and uninsured. For these high-risk, underserved populations, the added support and higher sensitivity of the FIT-DNA test acted as a critical bridge, helping to overcome persistent social and economic barriers to care.

Pro Tip for Providers: When selecting a FIT kit for routine use, consider the specific performance and brand of the kit. Variations in test performance can influence the number of abnormal results, which directly impacts the subsequent demand for colonoscopies in your facility.

The “Last Mile” Problem: The Colonoscopy Gap

While mailed kits are solving the initial screening problem, a dangerous gap remains in the follow-up process. A screening test is only a first step; if the result is abnormal, a follow-up colonoscopy is mandatory to diagnose or remove precancerous polyps.

The recent study revealed a sobering statistic: among 1,435 screened participants, 100 had abnormal results, but fewer than 4 in 10 completed the necessary follow-up colonoscopy within 180 days.

This suggests that while “mailing the test” works, “navigating the procedure” is where the system is still failing. Future trends in CRC prevention will likely move toward “enhanced navigation,” where patients with abnormal results receive aggressive, personalized support to ensure they actually reach the operating table.

Future Trends to Watch

  • Integrated Navigation: Moving from automated reminders to human-led patient navigators who handle scheduling and transportation.
  • Manufacturer-Clinician Partnerships: Deeper integration between test manufacturers and community health centers to streamline the transition from a positive home test to a clinical procedure.
  • Hyper-Localized Outreach: Tailoring outreach materials to specific linguistic and cultural needs, as seen in the success of targeted approaches in Los Angeles.

Frequently Asked Questions

What is the difference between FIT and FIT-DNA?

FIT (Fecal Immunochemical Test) looks for tiny amounts of blood in the stool. FIT-DNA combines the blood test with a search for specific DNA mutations associated with colorectal cancer, generally offering higher sensitivity.

Colorectal cancer screening options – Pick a test, get it done! I UCLA Health

How often should these tests be performed?

While FIT is typically an annual test, FIT-DNA is generally performed every three years.

Why is a colonoscopy necessary after a positive stool test?

Stool tests are screening tools that indicate a possibility of cancer or polyps. A colonoscopy is the gold standard because it allows a doctor to actually see the colon and remove precancerous polyps on the spot, preventing cancer from developing.

Why do some people fail to complete follow-up colonoscopies?

Barriers often include lack of insurance, transportation issues, fear of the procedure, or a lack of coordinated support from the healthcare provider.

Aim for to stay updated on the latest in preventative health? Join the conversation in the comments below or subscribe to our newsletter for deep dives into the medical trends shaping the future of community care.

Read the full study in JAMA Internal Medicine.

0 comments
0 FacebookTwitterPinterestEmail
Health

Why Are Young People Getting Colon Cancer? Weed Killer May Be Linked

by Chief Editor
written by Chief Editor

The Hidden Link Between Herbicides and Early-Onset Cancer

For years, medical professionals have been puzzled by a mysterious global trend: the rising incidence of colorectal cancer in adults under 50. Although colon cancer was traditionally viewed as a disease of the elderly, a groundbreaking study published in Nature Medicine has pointed to a potential environmental culprit.

From Instagram — related to The Hidden Link Between Herbicides and Early, Onset Cancer For

Researchers have identified a possible link between picloram—a common herbicide used globally to eliminate woody plants and shrubs—and the increase in young colorectal cancer cases. Unlike some chemicals that break down quickly, picloram is known to persist in the soil for years, creating a long-term exposure risk.

Interestingly, the study found that picloram did not appear to be significantly linked to colorectal cancer in adults over 70, suggesting that the impact of this chemical may be specifically tied to the biological vulnerabilities of younger populations.

Did you know? Picloram was developed in the 1960s and was one of several herbicides used in “agents” by the US Military to clear forests during the Vietnam War.

The Role of Epigenetic Footprints

Recent findings suggest that certain weed killers may leave a “hidden epigenetic footprint” in early-onset colon cancer. Which means the chemicals may not just damage DNA directly but could alter how genes are expressed, potentially triggering the development of tumors over several decades.

The Role of Epigenetic Footprints
Mediterranean Beyond The Role of Epigenetic Footprints Recent

But, experts caution that the picture is complex. Robin Mesnage of King’s College London notes that real-world exposure often involves more than just the active ingredient. Contaminants or co-formulants used during manufacturing, such as the known carcinogen hexachlorobenzene, could also be contributing factors.

Beyond the Garden: A Multifactorial Crisis

While the discovery of picloram provides a critical clue, scientists agree that no single factor is responsible for the rise in young colon cancer. Instead, it is likely a combination of modern lifestyle drivers and environmental exposures.

Key risk factors currently under scrutiny include:

  • Dietary Deficiencies: A lack of “Mediterranean” staples, including fresh vegetables, beans, and nuts.
  • Lifestyle Factors: High rates of obesity and the continued impact of smoking.
  • Socioeconomic Indicators: Educational attainment, which often correlates with access to healthier diets.
Pro Tip: Incorporating more fiber-rich legumes and nuts into your daily routine can help align your diet with Mediterranean patterns known to support gut health.

The Future of Prevention: Microbiomes and Probiotics

As we gaze toward future trends in oncology, the focus is shifting toward the gut microbiome. Beyond chemicals, researchers are investigating the role of early-life bacterial infections.

Why More Young People Are Getting Colon Cancer

One specific area of interest is colibactin bacteria infections occurring in infancy. As colon cancer takes decades to develop, an infection in early childhood could potentially set the stage for cancer in early adulthood.

The future of prevention may lie in biotechnology. Scientists are exploring the possibility of using specially designed probiotics to combat these bacterial threats, potentially neutralizing the risk before it ever evolves into a malignancy.

Navigating the New Screening Landscape

The shift in cancer demographics has already led to tangible changes in medical guidelines. In 2021, the US lowered the recommended age for initial colonoscopy screenings from 50 to 45 years classic.

This change reflects a broader medical trend: the move toward earlier detection for “young-onset” diseases. As more environmental drivers like picloram are identified, we may see further personalization of screening schedules based on a patient’s history of chemical exposure or microbiome profile.

Frequently Asked Questions

Is picloram found in all weed killers?

No, picloram is specifically used for woody plants and shrubs while leaving grasses intact. It is not present in every herbicide, but it is used globally.

Does this mean I should be screened before age 45?

Current US guidelines recommend screening start at 45. However, Make sure to consult a doctor if you have a family history or specific risk factors.

Can a Mediterranean diet actually lower my risk?

Experts point to diets rich in fresh vegetables, beans, and nuts as protective factors against colorectal cancer.

Join the Conversation: Are you surprised by the link between garden chemicals and health? Have you noticed changes in your family’s health screening recommendations? Let us know in the comments below or subscribe to our newsletter for the latest medical breakthroughs.

0 comments
0 FacebookTwitterPinterestEmail
Health

His Dad Began Chemotherapy on His 16th Birthday

by Chief Editor
written by Chief Editor

The Rising Tide of Young-Onset Colorectal Cancer: A Teenager’s Perspective

Colorectal cancer is no longer solely a disease of older adults. Increasingly, diagnoses are occurring in individuals under 50, impacting not only those directly affected but also their families – especially children and teenagers navigating a parent’s illness. Dylan Kurtz, who shared his experience as his father battled stage 3 colon cancer beginning on his 16th birthday in 2020, offers a poignant look into this growing trend and valuable advice for others facing similar challenges.

A Shocking Diagnosis: When Cancer Hits Home

Dylan Kurtz’s story began with a surprise. His father, Jonathan, began chemotherapy on Dylan’s 16th birthday. Initially, Dylan didn’t fully grasp the implications. “I didn’t really know much of anything about colon cancer other than it was cancer in the colon,” he explained. The emotional uncertainty was overwhelming, but open communication with his father helped him understand the seriousness of the situation, including the need for radiation and months of chemotherapy.

A Shocking Diagnosis: When Cancer Hits Home

This experience highlights a critical need for honest, age-appropriate conversations when a parent receives a cancer diagnosis. Marianne Pearson, MSW, LCSW, vice president of Cancer Care at the Colorectal Cancer Alliance, emphasizes that explaining treatments and even visiting the cancer center can reduce fear and provide a sense of security.

Life Interrupted: Adapting to a Modern Normal

A cancer diagnosis ripples through the entire family. For Dylan, it meant a shift in routines and responsibilities. Family activities, like attending baseball games and outdoor adventures, were place on hold as his father’s health required prioritizing rest and minimizing exposure to germs, particularly during the COVID-19 pandemic. Instead of typical outings, they found new ways to connect, like completing puzzles together.

Dylan also stepped up at home, taking on extra chores, helping with meals, and providing care for his older brother, Steven, who has autism. He even created “Camp Kurtz” when summer camps were canceled, ensuring Steven remained engaged and supported.

The Importance of Accurate Information and Self-Advocacy

Initially, Dylan turned to the internet for answers, but quickly realized the potential for misinformation and alarming worst-case scenarios. He learned to rely on his parents and his father’s doctors for accurate information. This underscores the importance of avoiding self-diagnosis through online searches and seeking guidance from trusted medical professionals.

A Family History and the Future of Screening

Fortunately, Dylan’s father is now cancer-free, but the experience prompted a deeper understanding of preventative health. Dylan learned that screening is crucial for early detection and that his family may carry a genetic predisposition to colorectal cancer. He plans to undergo genetic testing and potentially begin screening at a younger age than typically recommended.

Cedrek McFadden, MD, medical advisor for the Colorectal Cancer Alliance, notes that children of parents diagnosed with colorectal cancer have a higher risk and should consider starting screening 10 years before their parent’s diagnosis, or at age 40, whichever comes first. Genetic counseling and testing are also important, especially if the cancer occurred at a young age or there’s a strong family history.

Spreading Awareness and Offering Support

Driven by his experience, Dylan Kurtz partnered with the Colorectal Cancer Alliance to create resources for teenagers navigating a parent’s cancer journey. He emphasizes the importance of avoiding unreliable online information, embracing increased family responsibilities (while communicating limits), finding new ways to connect with a parent during treatment, and seeking support from teachers, counselors, and friends.

Tom Milam, MD, psychiatrist and Chief Medical Officer at Iris Telehealth, points out that children often grapple with unspoken grief, fear, and sadness. Professional behavioral health support can be invaluable for both the child and the entire family.

Dylan’s Tips for Teens

  • Avoid Google: Rely on doctors and trusted resources for accurate information.
  • Embrace Responsibilities: Help at home, but don’t be afraid to ask for help if overwhelmed.
  • Find New Activities: Discover new ways to connect with your parent during treatment.
  • Seek Support: Talk to friends, family, teachers, or a counselor.

FAQ

Q: What should I do if my parent is diagnosed with colorectal cancer?
A: Talk to your parent and their doctors, seek support from friends and family, and don’t be afraid to ask for help.

Q: Is colorectal cancer becoming more common in younger people?
A: Yes, it is. Colorectal cancer has surpassed breast and lung cancer as the leading cause of cancer-related deaths in U.S. Adults under 50.

Q: How can I find reliable information about colorectal cancer?
A: Consult with your parent’s doctors, the Colorectal Cancer Alliance (https://www.colorectalcancer.org/), and other reputable medical organizations.

Q: What if I feel overwhelmed by my new responsibilities?
A: Communicate your feelings to your parents and seek support from others. It’s okay to ask for help.

Did you know? Colorectal cancer is often preventable with regular screening. Talk to your doctor about when you should start getting screened.

Share your story and help raise awareness about young-onset colorectal cancer. What resources have you found helpful? Leave a comment below.

0 comments
0 FacebookTwitterPinterestEmail
Health

Mom’s late-stage cancer symptoms dismissed by multiple doctors for years

by Chief Editor
written by Chief Editor

The Rising Tide of Colorectal Cancer in Younger Adults: A Wake-Up Call

A growing number of individuals in their 30s and 40s are receiving a colorectal cancer diagnosis, challenging conventional understanding of the disease. Marisa Peters, a 44-year-old Los Angeles mother of three, embodies this shift. For years, her symptoms – rectal bleeding, changes in bowel movements, and urgent needs to proceed – were dismissed as lingering effects of childbirth. It wasn’t until she was diagnosed with stage 3 colorectal cancer that the true cause was revealed.

Dismissed Symptoms and Delayed Diagnoses

Peters’ story isn’t unique. Doctors often attribute early symptoms to common postpartum issues, leading to delayed investigations. This is particularly concerning given that colorectal cancer is now the leading cause of cancer death in adults under 50, and the second leading cause overall in the United States. In 1995, adults 65 and younger comprised 27% of all new cases; today, that number has risen to nearly 45%.

“They didn’t realize the face of colorectal cancer had changed,” Peters explained to Fox News Digital. “It now looked like someone much younger.” The increasing incidence in younger populations highlights the need for greater awareness among both patients and healthcare providers.

The Importance of Early Screening

While Peters’ cancer was already advanced by the time of diagnosis, she emphasizes the importance of colonoscopies for those with concerns or risk factors. A colonoscopy is considered the “gold standard” for screening. Her sister, after learning of Peters’ diagnosis, underwent a colonoscopy and had pre-cancerous polyps removed, despite experiencing no symptoms. Peters also discovered her parents had previously removed pre-cancerous polyps.

“Knowing your family’s health history is tremendously essential,” Peters stated.

Beyond Genetics: Understanding the Shift

The reasons behind this surge in young-onset colorectal cancer remain unclear, but researchers are investigating potential contributing factors. While genetics play a role, the increase suggests environmental and lifestyle influences are also at play.

Taking Action: BE SEEN and Community Support

Driven by her experience, Peters co-founded BE SEEN, a nonprofit dedicated to advocating for earlier intervention and screening. The organization promotes resources and community programs, including “poop parties” designed to reduce anxiety and stigma surrounding colonoscopies.

BE SEEN aims to empower individuals to advocate for their health and seek timely medical attention when experiencing concerning symptoms. The organization also works to raise awareness about the changing face of colorectal cancer and the need for proactive screening.

What Symptoms Should You Watch For?

Recognizing the early warning signs is crucial. Key symptoms to be aware of include:

  • Rectal bleeding
  • Changes in bowel habits (diarrhea, constipation, or a change in the consistency of stool)
  • Persistent abdominal discomfort or cramping
  • A feeling of incomplete evacuation
  • Unexplained anemia

It’s important to remember that these symptoms can be caused by other conditions, but any persistent changes should be evaluated by a medical professional.

FAQ: Colorectal Cancer and Young Adults

Q: At what age should I start getting screened for colorectal cancer?
A: Official health agencies recommend starting screenings at age 45 for adults at average risk.

Q: I’m experiencing some of these symptoms. Should I be worried?
A: It’s always best to consult with a doctor to discuss your symptoms and determine the appropriate course of action.

Q: Is colorectal cancer preventable?
A: Colorectal cancer is often preventable through regular screening and the removal of pre-cancerous polyps.

Q: What is a colonoscopy?
A: A colonoscopy is a procedure where a doctor uses a long, flexible tube with a camera to examine the entire colon for polyps or other abnormalities.

Did you know? Colorectal cancer is highly treatable when detected early. Early detection significantly improves survival rates.

Pro Tip: Don’t hesitate to advocate for yourself. If you feel your concerns are being dismissed, seek a second opinion.

If you are experiencing any concerning symptoms, please consult with your healthcare provider. Early detection is key to improving outcomes. Learn more about colorectal cancer and screening options from reputable sources like the American Cancer Society.

Share this article with your friends and family to help raise awareness about this important health issue.

0 comments
0 FacebookTwitterPinterestEmail
Health

Exercise recommended as part of treatment for colon cancer

by Chief Editor
written by Chief Editor

Exercise Now Officially Part of Colon Cancer Treatment: A Paradigm Shift in Oncology

For decades, exercise has been relegated to a supportive role in cancer care – something to manage symptoms or improve quality of life during treatment. Now, a landmark shift is underway. The European Society for Medical Oncology (ESMO) has formally recognized tailored exercise as an integral part of the standard of care for patients undergoing treatment for stages 2 and 3 colon cancer.

The CO21 Challenge: Proof Positive

This groundbreaking change is rooted in the Canadian Cancer Trials Group CO21 Challenge, a 17-year study that definitively demonstrated the power of physical activity to improve cancer survival. The trial involved 889 patients with Stage 2 or 3 colon cancer who had completed chemotherapy. Participants were divided into two groups: one receiving standard health information and the other engaging in a structured exercise program – 2.5 hours of moderate weekly exercise – guided by physiotherapists or kinesiologists over three years.

The results were compelling. Those in the exercise group experienced a 37% lower risk of death and a 28% lower risk of cancer recurrence or the development of new cancers. This isn’t merely symptom management; it’s a tangible impact on survival rates.

From Quality of Life to Essential Treatment

“As far as we know, this is the first time that a non-medical intervention has been included in a treatment flow diagram by any clinical oncology group that provides practice guidelines,” explains Kerry Courneya, professor and Canada Research Chair in Physical Activity and Cancer at the University of Alberta. This signifies a fundamental shift in how oncology teams approach colon cancer treatment.

What Does This Mean for Patients?

The ESMO guidelines now explicitly recommend that eligible patients participate in organized exercise programs. The guidelines also utilize a standardized scoring system to highlight the strength of the evidence supporting exercise interventions. This isn’t a vague suggestion; it’s a call to action for healthcare professionals to actively discuss exercise as a treatment option with their patients.

Every patient diagnosed with Stage 2 or 3 colon cancer should be informed about the vital role exercise can play in their treatment journey and, ideally, be connected with a structured program to support their efforts.

Beyond Colon Cancer: The Potential for Wider Application

While the initial guidelines focus on colon cancer, the implications extend far beyond. Researchers are optimistic that similar recommendations will emerge for other cancer types. The underlying principle – that physical activity can modulate the body’s response to cancer treatment and improve outcomes – is applicable across a broad spectrum of malignancies.

The University of Alberta’s Department of Medical Oncology, in collaboration with the Cross Cancer Institute, is actively involved in research exploring the benefits of exercise for various cancers, including prostate cancer.

Future Trends: Personalized Exercise Prescriptions

The future of exercise oncology lies in personalization. Rather than a one-size-fits-all approach, treatment plans will increasingly incorporate individualized exercise prescriptions tailored to a patient’s specific cancer type, stage, treatment regimen, and overall health status. This will require close collaboration between oncologists, physiotherapists, kinesiologists, and other healthcare professionals.

Expect to notice more sophisticated monitoring tools – wearable sensors, activity trackers, and digital health platforms – used to track patient progress and adjust exercise programs accordingly. The integration of artificial intelligence and machine learning could further refine these personalized prescriptions, optimizing exercise interventions for maximum benefit.

Did you know?

Implementation of Enhanced Recovery After Surgery (ERAS) protocols, including exercise components, has already shown improvements in clinical outcomes for colorectal cancer patients in Alberta, as demonstrated in a 2016 cost impact analysis.

FAQ

Q: What type of exercise is recommended?
A: Moderate-intensity exercise, such as brisk walking, cycling, or swimming, is generally recommended. A structured program guided by a qualified professional is ideal.

Q: Is exercise safe during chemotherapy?
A: In most cases, yes. However, it’s crucial to discuss your exercise plan with your oncologist to ensure it’s appropriate for your individual situation.

Q: How much exercise is enough?
A: The CO21 Challenge utilized 2.5 hours of moderate weekly exercise, but the optimal amount may vary. Start slowly and gradually increase intensity and duration as tolerated.

Q: Where can I find a qualified exercise professional?
A: Your oncologist or cancer care team can provide referrals to physiotherapists or kinesiologists specializing in cancer rehabilitation.

Pro Tip: Don’t wait until you’re feeling your worst to start exercising. Incorporate physical activity into your routine as early as possible in your cancer journey.

Want to learn more about the latest advancements in cancer care? Explore ESMO’s webinar series on colorectal cancer.

Share your thoughts! How do you think this change in guidelines will impact cancer care? Exit a comment below.

0 comments
0 FacebookTwitterPinterestEmail
Health

Doctors encourage early screening for Colon Cancer Awareness Month

by Chief Editor
written by Chief Editor

Colon Cancer Screening: Why 45 is the Recent 50

March is Colon Cancer Awareness Month, a crucial time to discuss a cancer that often progresses silently. Recent shifts in medical guidelines are prompting more people to consider screening earlier than previously thought. What’s driving this change and what does it mean for your health?

The Rising Tide of Early-Onset Colon Cancer

For decades, the recommended age to begin regular colon cancer screening was 50. However, doctors are now observing a concerning trend: an increase in diagnoses among younger adults. Dr. Aaron Guercio, a general surgeon at Cassia Regional Hospital, notes that guidelines have shifted to 45 as a result. This isn’t simply a matter of increased awareness; the incidence of colon cancer in individuals under 50 is genuinely rising.

This shift underscores the importance of proactive health management. While genetics play a role, lifestyle factors are too significant contributors. Factors like alcohol consumption, smoking, diet, and obesity can all increase your risk.

The Silent Threat: Understanding Colon Cancer Symptoms

One of the most dangerous aspects of colon cancer is its often asymptomatic nature. As Dr. Guercio explains, many individuals have no idea they have the disease until it reaches an advanced stage – stage 3 or 4.

Early symptoms, when they do appear, can be subtle and easily dismissed. These might include:

  • Gnawing abdominal pain
  • Blood in bowel movements
  • Loss of appetite
  • Unexplained weight loss

It’s vital to remember that these symptoms can indicate other conditions, but they warrant a conversation with your doctor. Don’t wait for symptoms to appear; early detection is key.

Screening Options: Colonoscopy and At-Home Tests

If you’re 45 or older, or have a family history of colon cancer, it’s time to discuss screening options with your primary care provider. The gold standard remains the colonoscopy, a procedure that allows doctors to visualize the entire colon and remove any precancerous polyps.

However, colonoscopies aren’t the only option. At-home testing kits are available, offering a less invasive initial screening method. These kits can help determine if a follow-up colonoscopy is necessary.

Pro Tip: Don’t be intimidated by the preparation for a colonoscopy. The discomfort is temporary, and the potential benefits – early detection and prevention – are significant.

The Importance of Early Detection

Early detection dramatically improves treatment outcomes. By identifying and removing precancerous polyps, colon cancer can often be prevented altogether. Even if cancer is detected at an early stage, treatment is typically more effective and less invasive.

Frequently Asked Questions

Q: What is the main cause of colon cancer?
A: While the exact cause isn’t always clear, it’s often a combination of genetic predisposition and lifestyle factors.

Q: How often should I obtain a colonoscopy?
A: This depends on your individual risk factors and the results of previous screenings. Your doctor will advise you on the appropriate schedule.

Q: Are there any dietary changes I can make to reduce my risk?
A: A diet rich in fiber, fruits, and vegetables, and low in processed foods and red meat, may help lower your risk.

Q: What if I’m hesitant about getting a colonoscopy?
A: Talk to your doctor about your concerns. They can explain the procedure in detail and address any anxieties you may have.

Did you know? Colon cancer is the leading cause of cancer-related deaths for both men and women in the U.S.

Capture control of your health. Discuss colon cancer screening with your doctor today. For more information, visit The American Cancer Society or The Centers for Disease Control and Prevention.

What questions do *you* have about colon cancer screening? Share them in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

Colorectal cancer rates surge among adults under 65 across US

by Chief Editor
written by Chief Editor

Colorectal Cancer’s Alarming Rise in Younger Adults: A Deep Dive

Colorectal cancer (CRC), once largely considered a disease of older adults, is now increasingly affecting younger generations. A modern report, “Colorectal Cancer Statistics, 2026,” from the American Cancer Society, reveals a significant shift in incidence, with those 65 and under now accounting for 45% of all new cases – a dramatic increase from 27% in 1995.

The Shifting Demographics of Colorectal Cancer

The most concerning trend is the rapid rise in diagnoses among adults aged 20 to 49, increasing at a rate of 3% per year. This surge has led to colorectal cancer becoming the leading cause of cancer death in adults under 50. While rates are declining in seniors, the younger demographic is experiencing a worrying uptick in the disease.

Currently, approximately 158,850 new cases of colorectal cancer are projected to be diagnosed this year, resulting in 55,230 deaths. The report, published in CA: A Cancer Journal for Clinicians, highlights a particularly troubling statistic: 75% of colorectal cancers in adults 50 and under are diagnosed at an advanced stage. Half of these diagnoses occur between the ages of 45 and 49.

Rectal Cancer on the Rise

Beyond overall colorectal cancer rates, the report also indicates a rise in rectal cancer specifically. Rectal cancer now accounts for about one-third (32%) of all CRC cases, up from 27% in the mid-2000s. This increase adds another layer of complexity to the evolving landscape of this disease.

Screening Rates and the 45-49 Age Group

Despite being eligible for routine screenings, only 37% of individuals in the 45-49 age group actually undergo them. This low screening rate contributes to the higher proportion of advanced-stage diagnoses in younger adults. Early detection is crucial, as the five-year survival rate for localized (early-stage) colorectal cancer is 95%.

What’s Driving This Increase?

Rebecca Siegel, senior scientific director at the American Cancer Society and lead author of the report, emphasizes the need for further research. “After decades of progress, the risk of dying from colorectal cancer is climbing in younger generations of men and women, confirming a real uptick in disease because of something we’re doing or some other exposure,” she stated. Researchers are investigating potential contributing factors, but a definitive cause remains elusive.

More than half of CRC cases are linked to modifiable risk factors, including poor nutrition, high alcohol consumption, smoking, lack of exercise, and obesity. Addressing these lifestyle factors could potentially mitigate the rising incidence of the disease.

The Importance of Early Detection and Research

Dr. William Dahut, chief scientific officer at the American Cancer Society, underscores the importance of continued research and increased screening. “These findings further underscore that colorectal cancer is worsening among younger generations and highlight the immediate need for eligible adults to start screening at the recommended age of 45,” he said. “The report also shines a light on the crucial importance of continued funding for research to help discover new therapies to treat the disease and advance patient care.”

Frequently Asked Questions

What is colorectal cancer? Colorectal cancer is a cancer that starts in the colon or rectum.

Who is at risk? While anyone can develop colorectal cancer, risk factors include age, family history, lifestyle choices, and certain medical conditions.

When should I start getting screened? Current guidelines recommend that individuals begin regular screenings at age 45.

What are the symptoms of colorectal cancer? Symptoms can include changes in bowel habits, rectal bleeding, abdominal discomfort, and unexplained weight loss.

Is colorectal cancer preventable? Adopting a healthy lifestyle, including a balanced diet, regular exercise, and avoiding smoking, can help reduce your risk.

0 comments
0 FacebookTwitterPinterestEmail
Health

New research initiative aims to predict and prevent diseases before they start

by Chief Editor
written by Chief Editor

The Dawn of Predictive Medicine: How Military Data is Pioneering Disease Prevention

Imagine a future where doctors don’t just treat illness, but prevent it – years before symptoms even appear. This isn’t science fiction, but the ambitious goal of ORIGIN, a groundbreaking research initiative launched by the Icahn School of Medicine at Mount Sinai in collaboration with the Uniformed Services University of the Health Sciences (USU) and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF).

Unlocking the Secrets Within: The Power of ‘Omics’

ORIGIN aims to analyze blood samples from up to 13,000 active-duty U.S. Service members, collected years before any diagnosis, utilizing advanced molecular tools. These tools – proteomics, exposomics, metabolomics, and genomics – collectively known as “omics,” allow researchers to examine the body’s complex biological systems at a granular level. By identifying subtle changes and risk factors, the project hopes to map the molecular pathways leading to disease.

Why Study Service Members? A Unique Data Resource

U.S. Military personnel offer a unique advantage for this type of research. Their comprehensive, routine health monitoring creates an unparalleled long-term medical record. The Department of Defense Serum Repository (DoDSR) holds millions of longitudinal blood samples, many collected a decade or more before illness emerges. This resource is a scientific treasure trove, providing researchers with a window into the preclinical stages of disease.

Beyond a Single Disease: A Holistic Approach to Prevention

ORIGIN isn’t focused on just one condition. It’s a multidisciplinary study examining over 25 diseases simultaneously, including rheumatoid arthritis, lupus, multiple sclerosis, Crohn’s disease, neurodegenerative disease, post-traumatic stress disorder (PTSD), colon cancer, lung cancer, and heart failure. This broad scope is powered by the Precision Immunology Institute at Mount Sinai (PrIISM), which fosters collaboration between specialists who traditionally work in silos.

This collaborative approach is key. By breaking down barriers between departments – cardiology, immunology, neurology, oncology, and more – researchers can identify shared biological pathways and develop treatments that address multiple conditions simultaneously.

Environmental Factors and Disease Risk: The Impact of Military Exposures

ORIGIN will also investigate the impact of military-specific environmental exposures on disease risk. Researchers will examine how factors like burn pits and per- and polyfluoroalkyl substances (PFAS, often called “forever chemicals”) alter the body’s biology and contribute to the development of chronic illnesses. This research could have significant implications for understanding and mitigating the health effects of environmental toxins.

Key Questions ORIGIN Aims to Answer

  • What molecular changes occur five years before a lupus diagnosis?
  • What precedes early-onset colon cancer – a rising concern in younger adults – by three years?
  • How do environmental exposures impact disease risk?

The Future of Medicine: From Reaction to Proaction

The potential impact of ORIGIN extends far beyond the military community. The insights gained from this research could revolutionize clinical guidelines, drug development, and public health policy. By identifying individuals at risk before they become ill, doctors could implement preventative measures – lifestyle changes, targeted therapies, or closer monitoring – to delay or even prevent disease onset.

“For years, we have dreamed of being able to tell a patient: ‘We see this coming, and here is what we can do about it,’” said Jean-Frédéric Colombel, MD, Professor of Medicine (Gastroenterology) and Co-Director, The Helmsley Inflammatory Bowel Disease Center, Icahn School of Medicine at Mount Sinai, and Co-Principal Investigator, ORIGIN.

FAQ: Predictive Medicine and the ORIGIN Study

Q: What is ‘omics’ technology?
A: ‘Omics’ refers to a suite of advanced molecular tools – proteomics, exposomics, metabolomics, and genomics – used to analyze the body’s complex biological systems at a granular level.

Q: How long will the ORIGIN study last?
A: The project is expected to run for at least 10 years, analyzing samples collected between October 2003 and September 2025.

Q: Will the findings from ORIGIN be available to the public?
A: The research team anticipates that the findings will reshape clinical guidelines, drug development, and public health policy.

Q: What is PrIISM?
A: PrIISM (Precision Immunology Institute at Mount Sinai) is a collaborative institute designed to break down traditional medical silos and foster interdisciplinary research.

Did you know? The DoD Serum Repository contains millions of blood samples, offering an unprecedented opportunity to study the preclinical stages of disease.

Pro Tip: Staying informed about advancements in medical research can empower you to take proactive steps towards your own health and well-being.

Learn more about the Icahn School of Medicine at Mount Sinai: https://icahn.mssm.edu/

What are your thoughts on the future of predictive medicine? Share your comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

Capital District Colon & Rectal Surgery Associates Welcomes Dr. Thomas Tritt

by Chief Editor
written by Chief Editor

The Future of Colorectal Surgery: Minimally Invasive Techniques and Personalized Care

The arrival of Dr. Thomas Tritt at Capital District Colon & Rectal Surgery Associates signals a broader trend in healthcare: a move towards specialized, advanced care for colorectal conditions. Board-certified general surgeons like Dr. Tritt, specializing in colon and rectal surgery, are increasingly focused on providing compassionate and effective treatment for a range of digestive health issues.

The Rise of Minimally Invasive Surgery

Dr. Tritt’s expertise in minimally invasive and robotic techniques isn’t just a current trend; it’s shaping the future of colorectal surgery. Traditionally, many colorectal procedures required large incisions, leading to longer recovery times and increased pain. Minimally invasive approaches, however, utilize smaller incisions, often with the assistance of robotic systems, resulting in less scarring, reduced blood loss, and faster healing.

Pro Tip: Ask your surgeon about their experience with minimally invasive techniques and whether they are a good fit for your specific condition.

Enhanced Recovery After Surgery (ERAS) protocols, too a focus for Dr. Tritt, complement minimally invasive techniques. ERAS protocols are evidence-based care bundles designed to optimize patient recovery, reducing hospital stays and improving overall outcomes. These protocols often involve patient education, pain management, and early mobilization.

Personalized Treatment Plans for Complex Conditions

Colorectal health isn’t a one-size-fits-all field. Dr. Tritt’s broad range of professional interests – encompassing colon cancer, rectal cancer, anal cancer, benign colon disorders, inflammatory bowel disease, inherited polyposis syndromes, fecal incontinence, and ano-rectal conditions – highlights the demand for personalized treatment plans.

For example, advancements in genetic testing are allowing doctors to identify individuals at higher risk for inherited polyposis syndromes, enabling proactive screening and preventative measures. Similarly, understanding the specific microbiome composition of patients with inflammatory bowel disease is leading to tailored dietary and therapeutic interventions.

The Role of Endoscopy and Advanced Diagnostics

Endoscopy remains a cornerstone of colorectal health, allowing for visualization of the colon and rectum to detect abnormalities. However, the technology is constantly evolving. High-definition endoscopes, coupled with advanced imaging techniques, are improving the accuracy of diagnoses.

Did you know? Regular colonoscopies are recommended for individuals over 45 to screen for colorectal cancer, one of the leading causes of cancer deaths in the United States.

Access to Specialized Care in the Capital District

The addition of Dr. Tritt to Capital District Colon & Rectal Surgery Associates expands access to specialized colorectal care in the Albany area. Located at 319 S. Manning Blvd., Suite 310, the practice welcomes new patients and can be reached at 518-438-2776. This is part of a larger network, St. Peter’s Health Partners Medical Associates, which includes over 1,100 physicians and advanced practitioners across more than 130 locations.

Frequently Asked Questions

What is a colorectal surgeon? A colorectal surgeon specializes in the surgical and non-surgical treatment of diseases of the colon, rectum, and anus.

What are the benefits of minimally invasive surgery? Minimally invasive surgery typically results in smaller incisions, less pain, reduced blood loss, and faster recovery times.

What is an ERAS protocol? ERAS (Enhanced Recovery After Surgery) protocols are evidence-based care bundles designed to optimize patient recovery after surgery.

When should I see a colorectal surgeon? Consider see a colorectal surgeon if you experience persistent changes in bowel habits, rectal bleeding, abdominal pain, or other concerning symptoms.

Learn more about colorectal health and find a specialist by visiting St. Peter’s Health Partners.

Have questions about your colorectal health? Share them in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

James Van Der Beek’s death follows rise of colon cancer in healthy 40-somethings

by Chief Editor
written by Chief Editor

The Rising Tide of Colorectal Cancer: Why Younger Adults Demand to Be Aware

The recent passing of actor James Van Der Beek at age 48 after a battle with colorectal cancer has brought renewed attention to a disturbing trend: a significant increase in colorectal cancer (CRC) diagnoses among younger individuals. While often considered a disease of older adults, CRC is now impacting people at an alarming rate, prompting experts to urge increased awareness and earlier screening.

Van Der Beek’s Story: A Wake-Up Call

Van Der Beek, known for his role in “Dawson’s Creek,” publicly shared his stage 3 colon cancer diagnosis in November 2024, having initially been diagnosed in August 2023. He revealed that a change in bowel movements was his first warning sign, initially attributed to coffee consumption. His experience highlights a crucial point: symptoms can be subtle and easily dismissed, even by those who are otherwise healthy.

A Shift in Demographics: Why the Increase?

Colorectal cancer was the fifth deadliest cancer for young adults in the 1990s. Now, it’s the second leading cause of cancer-related deaths in this age group. While overall cancer deaths have declined for younger people since 1990, CRC is the only major cancer showing a rise in mortality for those under 50. Experts don’t fully understand the reasons behind this shift, but believe it’s a complex interplay of risk factors, genetics, and environmental exposures.

Understanding the Risk Factors

Several factors can contribute to an increased risk of colorectal cancer. These include family history, obesity, smoking, a diet high in red and processed meats, inflammatory bowel disease, and a personal or family history of polyps. Emerging research also points to the potential impact of ultraprocessed foods and early life exposures, such as antibiotics.

Recognizing the Red Flags: Symptoms to Watch For

Early-stage colorectal cancer often presents no noticeable symptoms. But, as the disease progresses, individuals may experience changes in bowel habits, stomach pain or abdominal discomfort, rectal bleeding or blood in stool, fatigue due to anemia, and unexplained weight loss. It’s key to remember that these symptoms can also be indicative of other conditions, but any persistent changes should be investigated by a healthcare professional.

The Importance of Screening

Early detection is key to improving outcomes in colorectal cancer. Colonoscopy, starting at age 45, is considered the most effective screening method. It allows for the detection and removal of precancerous polyps before they develop into malignant tumors. Other options, like stool-based tests, are also available, but colonoscopy remains the gold standard.

The Role of Lifestyle and Diet

While genetics play a role, lifestyle factors are increasingly recognized as significant contributors to CRC risk. Reducing consumption of red and processed meats, maintaining a healthy weight, and avoiding smoking are all important steps individuals can take to lower their risk. A diet rich in fiber and fruits and vegetables is also recommended.

What Experts Are Saying

Dr. Eitan Friedman emphasizes the importance of colonoscopy for early detection, while Dr. Erica Barnell highlights the need to improve screening compliance, particularly in underserved communities. The message is clear: proactive screening and awareness are crucial in combating this growing health concern.

FAQ: Colorectal Cancer and Early Detection

  • At what age should I start getting screened for colorectal cancer? The recommended screening age is now 45, but individuals with a family history or other risk factors may need to start earlier.
  • What are the common symptoms of colorectal cancer? Changes in bowel habits, rectal bleeding, abdominal pain, and unexplained weight loss are potential symptoms.
  • Is a colonoscopy painful? Colonoscopies are typically performed with sedation, minimizing discomfort.
  • Can I reduce my risk of colorectal cancer through lifestyle changes? Yes, maintaining a healthy weight, eating a balanced diet, and avoiding smoking can all help lower your risk.

Did you know? Colorectal cancer is often preventable with regular screening and lifestyle modifications.

Pro Tip: Don’t hesitate to discuss any concerns about your digestive health with your doctor. Early detection can significantly improve your chances of successful treatment.

If you are experiencing any concerning symptoms, please consult with your healthcare provider. Learn more about colorectal cancer and screening options at The American Cancer Society.

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts